Palonosetron for the prevention of chemotherapy-induced nausea and vomiting: approval and efficacy

Abstract

Chemotherapy-induced nausea and vomiting (CINV) is associated with a significant deterioration in quality of life. The emetogenicity of the chemotherapeutic agents, repeated chemotherapy cycles, and patient characteristics (female gender, younger age, low alcohol consumption, history of motion sickness) are the major risk factors for CINV. This review… (More)
DOI: 10.1586/14737140.2013.814412

3 Figures and Tables